Health Catalyst Inc is primarily active in the healthcare industry.

Some of the main competitors of Health Catalyst Inc in the market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, and McKesson Corporation.

Health Catalyst Inc is a leading provider of data and analytics in the healthcare industry. Founded in 2008, the company has quickly gained prominence for its innovative approach to improving healthcare outcomes through data-driven insights. Health Catalyst offers a comprehensive suite of solutions designed to help healthcare organizations organize, analyze, and leverage their data to drive decision-making and improve patient care. With a strong focus on value-based care and population health management, Health Catalyst has established itself as a trusted partner for healthcare organizations seeking to transform their operations and achieve better patient outcomes.

Health Catalyst Inc, a leading healthcare analytics and data warehousing company, has achieved several significant milestones. Notably, the company successfully completed its initial public offering in July 2019, raising approximately $182 million. In 2020, Health Catalyst was named one of the Best Places to Work in Healthcare by Modern Healthcare. Furthermore, the company has consistently expanded its customer base, delivering data-driven solutions to over 150 healthcare organizations. Health Catalyst's innovative use of artificial intelligence and machine learning technologies has also gained recognition, contributing to the company's growth and success in improving healthcare outcomes.

Health Catalyst Inc is primarily present in the United States.

Health Catalyst Inc is a leading provider of data and analytics solutions for healthcare organizations. The company represents values such as innovation, collaboration, and a patient-centric approach. With a focus on improving healthcare outcomes, Health Catalyst Inc emphasizes the importance of data-driven decision-making and empowering healthcare professionals with actionable insights. Their corporate philosophy revolves around driving meaningful change in the healthcare industry through leveraging advanced analytics and technology. By offering transformative solutions, Health Catalyst Inc aims to enable healthcare organizations to deliver better patient care, reduce costs, and enhance operational efficiency.

Analysts currently set an average price target of 3,95 USD for the Health Catalyst stock (median: 3,95 USD), implying +76,1 % versus the latest price. The consensus is based on 17 analyst ratings.

Health Catalyst Analyytikkojen kursstavoitteet 2026

17 analysts currently rate the Health Catalyst stock: 8 recommend buying, 9 holding and 0 selling. For 2026, analysts expect Health Catalyst to generate revenue of 263,28 M USD and earnings per share of 0,04 USD.

Health Catalyst Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Health Catalyst share trades at 1,81 EUR (2,09 USD).

The Health Catalyst share (HCAT) is listed on 2 stock exchanges, including: NASDAQ (HCAT), Frankfurt (2YP.F).

Health Catalyst Inc is a US-based company specializing in the development of clinical analytics platforms. The company offers solutions for healthcare data analysis and data-driven decision support. Its business model is based on providing software and analytics tools to manage, integrate, analyze, and visualize clinical data. By combining the latest technologies in data analytics and business intelligence with deep expertise in healthcare, Health Catalyst supports hospitals and health systems in improving patient care. The company consists of two main divisions: data warehousing and analytics. The data warehousing division involves developing and managing databases and integrating data from various sources to obtain a comprehensive view of a facility's clinical performance and enable informed decision-making. The analytics division focuses on implementing analytics tools and methods to analyze the collected data and transform it into meaningful insights. Health Catalyst's product range includes solutions for population health management, improving clinical outcomes, and reducing healthcare costs. This includes clinical analytics and visualization tools, population health management platforms, data integration and storage solutions, and healthcare analytics services. The Health Catalyst data platform is an open system capable of processing both structured and unstructured data in real-time. This allows customers to easily integrate and analyze their data for informed decision-making. The target customers of Health Catalyst are hospitals and health systems in the United States facing increasing competitive pressure and growing demand for high-quality patient care. The company addresses the need to reduce healthcare costs, improve patient care, and optimize health processes. Health Catalyst's business model relies on recurring revenue from selling subscriptions to use the software platform and providing analytics tools and services. Additionally, the company offers training, consulting services, and technical support. In summary, Health Catalyst creates value for its customers by providing advanced tools to improve healthcare and achieve cost savings. The company's business model is also focused on recurring subscription revenue and additional service fees. By focusing on improving clinical outcomes, Health Catalyst demonstrates enthusiasm for healthcare and a passionate commitment to enhancing patient well-being.

odotettu liikevaihto Health Catalyst on 263,28 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Health Catalyst on 2,93 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Health Catalyst:n hinta-voitto-suhde (P/E) on tällä hetkellä 50,70. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Health Catalyst-osakkeen arvostusta.

Health Catalyst:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,56. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Health Catalyst-osakkeen arvostuskennuslukuna.

Health Catalyst:n Eulpool-laatuscore on 2/10.

Health Catalyst:n ISIN on US42225T1079. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Health Catalyst:n WKN on A2PH3J. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Health Catalyst:n ticker on HCAT. Tämä pörssinoteeraus käytetään Health Catalyst-osakkeiden kauppaan pörssissä.

Health Catalyst maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Health Catalyst kuuluu sektoriin 'Terveydenhuolto'.

Health Catalyst:n osingot jaetaan valuutassa USD.